鱼跃医疗收盘上涨3.67%，滚动市盈率19.49倍，总市值345.15亿元

Company Overview - Yuyue Medical's stock closed at 34.43 yuan, up 3.67%, with a rolling PE ratio of 19.49 times and a total market capitalization of 34.515 billion yuan [1] - The company ranks 46th in the medical device industry, which has an average PE ratio of 46.40 times and a median of 34.81 times [1] - As of April 10, 2025, Yuyue Medical had 40,000 shareholders, a decrease of 9,184 from the previous count, with an average holding value of 352,800 yuan and an average holding of 27,600 shares per shareholder [1] Business Operations - Yuyue Medical specializes in the research, manufacturing, and sales of medical device products, providing related solutions [1] - The company's product focus includes respiratory oxygen, diabetes care, infection control solutions, home electronic testing, in vitro diagnostics, emergency and clinical equipment, and rehabilitation devices [1] - Major brands under Yuyue Medical include "Yuyue," "Jiefurou," "Huatuo," "Jinzhong," "An'er iodine," "Primedic," and "Liuliu Vision," with the Yuyue brand being well-recognized [1] Financial Performance - In the first quarter of 2025, Yuyue Medical reported revenue of 2.436 billion yuan, a year-on-year increase of 9.17%, while net profit was 625 million yuan, reflecting a year-on-year decrease of 5.26% [2] - The company's gross profit margin stood at 50.30% [2]